Katsuya Takasu Clinic Director: Matsumoto Hitoshi, Who Appeared in Commercials, “Declined His Fee” – Sanspo

News Summary

Katsuya Takasu, director of Takasu Clinic, revealed that Matsumoto Hitoshi, who appeared in a commercial, declined his fee. This can be seen as an example of how to respond to unforeseen circumstances in promotional activities utilizing celebrities. In the context of medical institution M&A and business succession, this highlights the importance of managing risks associated with external environmental changes.

M&A Medical Editorial Department’s Perspective

The fact that Director Takasu publicly announced Matsumoto Hitoshi’s refusal of his commercial fee might seem unrelated to the management or business succession of medical institutions at first glance. However, this situation underscores the significant impact that “reputational risk,” such as scandals or voluntary suspension of activities by a public figure acting as a spokesperson, can have on business continuity. Medical institutions are no exception; in many cases, the fame and reputation of the director or president are directly linked to the clinic’s brand image. Should any incident occur involving such a key person, it could lead to patient attrition and difficulty in acquiring new patients, potentially narrowing the options for business succession. The very act of a highly influential figure like Director Takasu publicizing such an event can serve as a message to management, reinforcing the importance of risk management.

Points Raised by This News

• The possibility that the personal risks of a prominent director can affect the business continuity of a clinic.
• The risk that the actions of a spokesperson can have an unexpected impact on the branding of a medical institution.
• The reality that even with the communication power of Director Takasu, a situation like a commercial actor declining their fee can occur.
• The renewed recognition of the importance of reputational risk management in the operation of medical institutions.

Practical Questions Arising from This News

• If a director appearing in commercials were to be involved in a scandal, what would happen to the clinic’s management?
• If a prominent director were to suddenly retire, would a clinic with no successor candidates have no choice but to close?
• Would a situation like the refusal of a commercial appearance fee affect M&A negotiations for a medical institution?

If You Feel “Should I Consult Too?”

If your institution’s director or president has significant media exposure, and their personal fame and reputation greatly contribute to the clinic’s patient acquisition, this news serves as an opportunity to consider the risks of “what if.” A business continuity plan (BCP) for when key personnel are absent, and consideration of third-party succession in preparation for unforeseen events, are essential to ensure your clinic’s sustainable growth and continued service to patients. Seeking advice from specialists early on is key to finding the best options.

M&A Medical (CentralMedience Inc.), as an M&A support institution certified by the Small and Medium Enterprise Agency, supports the business succession of medical corporations, hospitals, and clinics with a completely success-fee-based model. Consultations are accepted with strict confidentiality. Free consultations are available here.